Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Louis Pujol

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Lung Cancer (Amsterdam, Netherlands)|March 23, 2020
Cachexia - sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients receiving immune-checkpoint inhibitorsBenoît Roch, Amandine Coffy, Sandy Jean-Baptiste, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 1, 2021
Lung Cancer in FranceJean-Louis Pujol, Pascal-Alexandre Thomas, Philippe Giraud, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2008
Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancerMohammad Chakra, Jean Louis Pujol, Pierre-Jean Lamy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 2, 2008
Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomesWilliam Jacot, Ludovic Lhermitte, Nadège Dossat, et al.
The Annals of Thoracic Surgery|December 10, 2013
Impact of preoperative marking coils on surgical and pathologic management of impalpable lung nodulesSébastien Bommart, Arnaud Bourdin, Grégory Marin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 26, 2021
Increasing Transparency in Author Contributions to Manuscripts: Enhanced Policy on Ghost and Honorary AuthorshipsAlex A Adjei, Sai-Hong Ignatius Ou, Cheryl Ho, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2014
Perception of lung cancer among the general population and comparison with other cancersJulien Mazières, Jean-Louis Pujol, Nikos Kalampalikis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 25, 2016
Lung Cancer Screening with Chest Computed Tomography in People Living with HIV: A Review by the Multidisciplinary CANCERVIH Working GroupAlain Makinson, Vincent Le Moing, Jacques Reynes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2007
Comparison of docetaxel- and vinca alkaloid-based chemotherapy in the first-line treatment of advanced non-small cell lung cancer: a meta-analysis of seven randomized clinical trialsJean-Yves Douillard, Silvy Laporte, Frank Fossella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2007
Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancerJohn R Eckardt, Joachim von Pawel, Jean-Louis Pujol, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Lung Cancer (Amsterdam, Netherlands)|March 23, 2020
Cachexia - sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients receiving immune-checkpoint inhibitorsBenoît Roch, Amandine Coffy, Sandy Jean-Baptiste, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 1, 2021
Lung Cancer in FranceJean-Louis Pujol, Pascal-Alexandre Thomas, Philippe Giraud, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2008
Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancerMohammad Chakra, Jean Louis Pujol, Pierre-Jean Lamy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 2, 2008
Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomesWilliam Jacot, Ludovic Lhermitte, Nadège Dossat, et al.
The Annals of Thoracic Surgery|December 10, 2013
Impact of preoperative marking coils on surgical and pathologic management of impalpable lung nodulesSébastien Bommart, Arnaud Bourdin, Grégory Marin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 26, 2021
Increasing Transparency in Author Contributions to Manuscripts: Enhanced Policy on Ghost and Honorary AuthorshipsAlex A Adjei, Sai-Hong Ignatius Ou, Cheryl Ho, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2014
Perception of lung cancer among the general population and comparison with other cancersJulien Mazières, Jean-Louis Pujol, Nikos Kalampalikis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 25, 2016
Lung Cancer Screening with Chest Computed Tomography in People Living with HIV: A Review by the Multidisciplinary CANCERVIH Working GroupAlain Makinson, Vincent Le Moing, Jacques Reynes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2007
Comparison of docetaxel- and vinca alkaloid-based chemotherapy in the first-line treatment of advanced non-small cell lung cancer: a meta-analysis of seven randomized clinical trialsJean-Yves Douillard, Silvy Laporte, Frank Fossella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2007
Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancerJohn R Eckardt, Joachim von Pawel, Jean-Louis Pujol, et al.
Pageof 10